CIDeRplusGeneral Information:
| Id: | 3,562 (click here to show other Interactions for entry) |
| Diseases: |
Diabetes mellitus, type II
- [OMIM]
Insulin resistance |
| Homo sapiens | |
| article | |
| Reference: | Bao Y et al.(2009) Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers J. Proteome Res. 8: 1623-1630 [PMID: 19714868] |
Interaction Information:
| Comment | Multivariate statistics indicated the rosiglitazone-mediated normalization of 8-10 key metabolites at 24 and 48 weeks, which were differentially expressed in diabetic subjects, involving glutamate, maltose, butanoate, glucuronolactone, C16:0, C18:1. In repaglinide and metformin groups, only glutamate and lysine (in repaglinide group at 48 week only) were brought to the normal level. |
|
Formal Description Interaction-ID: 33208 |
|
| Drugbank entries | Show/Hide entries for Metformin |